Lanifibranor and NASH resolution
Nat Rev Gastroenterol Hepatol
.
2021 Dec;18(12):832.
doi: 10.1038/s41575-021-00544-z.
Author
Eleni Kotsiliti
1
Affiliation
1
Nature Reviews Gastroenterology & Hepatology, . nrgasthep@springernature.com.
PMID:
34725496
DOI:
10.1038/s41575-021-00544-z
No abstract available
Publication types
Comment
MeSH terms
Benzothiazoles
Humans
Non-alcoholic Fatty Liver Disease* / diagnosis
Non-alcoholic Fatty Liver Disease* / drug therapy
Sulfonamides
Substances
Benzothiazoles
Sulfonamides
lanifibranor